These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 21301387)
1. HPV vaccination to prevent HIV infection: time for randomized controlled trials. van der Loeff MF; Nyitray AG; Giuliano AR Sex Transm Dis; 2011 Jul; 38(7):640-3. PubMed ID: 21301387 [No Abstract] [Full Text] [Related]
2. [Should the antipapillomavirus vaccination after the age of 25 be advised?]. Simon P; Poppe W J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37(8):748-52. PubMed ID: 18752907 [TBL] [Abstract][Full Text] [Related]
4. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519 [TBL] [Abstract][Full Text] [Related]
5. Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV Vaccination. Adcock R; Kang H; Castle PE; Kinney W; Emeny RT; Wiggins C; Wheeler CM JAMA Oncol; 2024 Sep; 10(9):1287-1290. PubMed ID: 39052303 [TBL] [Abstract][Full Text] [Related]
6. HPV vaccine and prevention of cervical cancer in Africa. Okonofua F Afr J Reprod Health; 2007 Aug; 11(2):7-12. PubMed ID: 20690283 [No Abstract] [Full Text] [Related]
7. HPV and HPV vaccine. Centers for Disease Control and Prevention J Med Assoc Ga; 2007; 96(1):45-7. PubMed ID: 17621907 [No Abstract] [Full Text] [Related]
8. Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. Rambout L; Hopkins L; Hutton B; Fergusson D CMAJ; 2007 Aug; 177(5):469-79. PubMed ID: 17671238 [TBL] [Abstract][Full Text] [Related]
9. Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program. Donken R; van Niekerk D; Hamm J; Spinelli JJ; Smith L; Sadarangani M; Albert A; Money D; Dobson S; Miller D; Lee M; Mitchell-Foster S; Krajden M; Naus M; Ogilvie G Int J Cancer; 2021 Jul; 149(1):191-199. PubMed ID: 33586169 [TBL] [Abstract][Full Text] [Related]
10. Search for HPV treatment vaccine heats up, researchers optimistic. McNeil C J Natl Cancer Inst; 2006 Jul; 98(14):954-5. PubMed ID: 16849674 [No Abstract] [Full Text] [Related]
11. Human papillomavirus-associated diseases in Israel--the controversy continues. Foreword. Bornstein J; Shavit O Vaccine; 2013 Nov; 31 Suppl 8():vii-x. PubMed ID: 24229722 [No Abstract] [Full Text] [Related]
12. HPV vaccines: what remains to be done? Interview by Lauren Constable. Zur Hausen H Expert Rev Vaccines; 2011 Nov; 10(11):1505-7. PubMed ID: 22043949 [No Abstract] [Full Text] [Related]
13. HPV-FASTER: Combined strategies of HPV vaccination and HPV screening towards a one visit for cervical cancer preventive campaigns. Bosch FX; Robles C Salud Publica Mex; 2018; 60(6):612-616. PubMed ID: 30699264 [No Abstract] [Full Text] [Related]
14. Prevention of human papilloma virus infection with vaccines. Azam F; Shams-ul-Islam M J Pak Med Assoc; 2010 Aug; 60(8):676-81. PubMed ID: 20726203 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys. Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194 [TBL] [Abstract][Full Text] [Related]
16. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221 [TBL] [Abstract][Full Text] [Related]
17. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial. Zhao FH; Zhu FC; Chen W; Li J; Hu YM; Hong Y; Zhang YJ; Pan QJ; Zhu JH; Zhang X; Chen Y; Tang H; Zhang H; Durand C; Datta SK; Struyf F; Bi D; Int J Cancer; 2014 Dec; 135(11):2604-11. PubMed ID: 24740547 [TBL] [Abstract][Full Text] [Related]
18. Letter to the editor response to the article of Luisa Lina Villa HPV prophylactic vaccination: the first years and what to expect from now, in press. Spinosa JP; Riva C; Biollaz J Cancer Lett; 2011 May; 304(1):70. PubMed ID: 21339044 [No Abstract] [Full Text] [Related]
19. The Importance of High-Risk Human Papillomavirus Types Other Than 16 and 18 in Cervical Neoplasia. Robadi IA; Pharaon M; Ducatman BS Arch Pathol Lab Med; 2018 Jun; 142(6):693-695. PubMed ID: 29848032 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer? Saleem A; Tristram A; Fiander A; Hibbitts S Minerva Med; 2009 Dec; 100(6):503-23. PubMed ID: 20010484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]